Intra-Cellular Therapies(ITCI) - 2024 Q1 - Quarterly Report

Washington, D.C. 20549 _______________________ FORM 10-Q _______________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 001-36274 _______________________ INTRA-CELLULAR THERAPIES, INC. (Exact name of registrant as specified in its charter) _______________________ Delaware 36-4742850 (State or other jurisdiction ...